{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:23Z","timestamp":1759104203532,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jneuroim.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,9]],"date-time":"2016-10-09T18:10:34Z","timestamp":1476036634000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis"],"prefix":"10.1016","volume":"300","author":[{"given":"Alicja","family":"Kalinowska-\u0141yszczarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miko\u0142aj A.","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Losy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Kozubski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.10.003_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archneur.57.4.546","article-title":"Adhesion molecules in multiple sclerosis relation to subtypes of disease and methylprednisolone therapy","volume":"57","author":"Elovaara","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-015-1417-0","article-title":"Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin \u03b1-4-transduced outside-in signalling","volume":"129","author":"Haarmann","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2005.06.019","article-title":"Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis","volume":"167","author":"Kuenz","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11910-007-0036-0","article-title":"New concepts on progressive multiple sclerosis","volume":"7","author":"Lassmann","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10384-005-0281-1","article-title":"Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan","volume":"50","author":"Lin","year":"2006","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(99)00092-2","article-title":"Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions","volume":"99","author":"Losy","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jocn.2013.06.013","article-title":"Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI","volume":"21","author":"Marques","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/WNL.56.10.1319","article-title":"Elevated plasma endothelial microparticles in multiple sclerosis","volume":"56","author":"Minagar","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","article-title":"Mechanisms of leukocyte transendothelial migration","volume":"6","author":"Muller","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0050","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.4049\/jimmunol.170.11.5704","article-title":"Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins","volume":"170","author":"Nakao","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","article-title":"Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica","volume":"85","author":"Tasaki","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0065","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneurol.2011.148","article-title":"Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica","volume":"68","author":"Uzawa","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tracli.2008.04.002","article-title":"Endothelial signalling by Ig-like cell adhesion molecules","volume":"15","author":"Van Buul","year":"2008","journal-title":"Transfus. Clin. Biol."},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus critera for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.10.003_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:40Z","timestamp":1759048060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816303253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":16,"alternative-id":["S0165572816303253"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}